Thymidylate synthase expression identifies hepatocellular carcinoma vulnerable to fluoropyrimidine-based therapy
Genes & Diseases
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитирование
Thymidylate synthase expression identifies hepatocellular carcinoma vulnerable to fluoropyrimidine-based therapy. // Genes & Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S2352304226002163?dgcid=rss_sd_all
Thymidylate synthase expression identifies hepatocellular carcinoma vulnerable to fluoropyrimidine-based therapy. Genes & Diseases. https://www.sciencedirect.com/science/article/pii/S2352304226002163?dgcid=rss_sd_all
“Thymidylate synthase expression identifies hepatocellular carcinoma vulnerable to fluoropyrimidine-based therapy.” Genes & Diseases.
@article{article3895,
title = {Thymidylate synthase expression identifies hepatocellular carcinoma vulnerable to fluoropyrimidine-based therapy},
journal = {Genes \& Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S2352304226002163?dgcid=rss_sd_all}
}